New drug cocktail tested for Tough-to-Treat blood cancer
Disease control
Recruiting now
This study is testing a combination of three drugs (acalabrutinib, venetoclax, and obinutuzumab) for people with mantle cell lymphoma, a type of blood cancer. It includes patients whose cancer has come back after treatment and those who have not yet been treated. The main goals a…
Phase: PHASE1, PHASE2 • Sponsor: Austin I Kim • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC